NYSE:GENGenesis Healthcare Competitors & Alternatives Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Genesis Healthcare Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.90 +0.01 (+1.12 %) (As of 06/5/2020 04:00 PM ET) Add Compare Share Today's Range$0.89Now: $0.90▼$0.9350-Day Range$0.59MA: $0.82▼$1.1652-Week Range$0.58Now: $0.90▼$1.86Volume934,249 shsAverage Volume582,421 shsMarket Capitalization$148.92 millionP/E Ratio2.44Dividend YieldN/ABeta1.31 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Competitors Genesis Healthcare (NYSE:GEN) Competitors and AlternativesThe following companies in the "medical" sector are considered alternatives and competitors to Genesis Healthcare.Competitor NameBeat the Market RankCurrent PricePrice ChangeMarket CapRevenueP/E RatioIndicator(s)CSTLCastle Biosciences1.4$37.69+0.5%$625.95 million$51.87 million-43.83Insider SellingATRAAtara Biotherapeutics1.3$9.74+0.8%$623.12 millionN/A-1.78Analyst DowngradeHeavy News ReportingARDXArdelyx1.6$6.92+0.1%$622.06 million$5.28 million-5.28Analyst DowngradeInsider SellingDBVTDBV TECHNOLOGIE/S1.7$5.17+1.0%$621.75 million$14.75 million-2.22Heavy News ReportingBLUBellus Health1.2$10.34+0.3%$612.92 millionN/A0.00Analyst UpgradeSNDXSyndax Pharmaceuticals1.6$16.89+0.7%$605.76 million$1.52 million-8.98YI1110.6$7.00+1.9%$598.22 million$567.68 million-7.78Heavy News ReportingDVAXDynavax Technologies2.1$6.09+6.4%$597.33 million$35.22 million-3.31Analyst UpgradeTRILTrillium Therapeutics1.6$7.15+2.8%$596.60 million$120,000.00-3.56Heavy News ReportingGNMKGenMark Diagnostics1.6$9.14+5.0%$594.45 million$88.02 million-12.69QTNTQuotient1.0$6.56+6.3%$590.29 million$29.13 million-4.23Upcoming EarningsPRVLPrevail Therapeutics1.5$16.62+3.4%$587.93 millionN/A-7.26Heavy News ReportingRDUSRadius Health1.9$12.25+2.7%$583.57 million$173.32 million-4.42Analyst DowngradePACBPacific Biosciences of California1.5$4.03+6.7%$577.76 million$90.89 million-11.85VAPOVapotherm0.9$30.23+4.1%$576.79 million$48.10 million-11.32Analyst ReportHeavy News ReportingFREQFrequency Therapeutics1.5$18.82+1.9%$572.50 million$28.95 million-8.22Insider SellingTVTYTivity Health2.1$11.38+5.0%$565.64 million$1.13 billion-1.13LNTHLantheus0.8$14.61+0.5%$564.94 million$347.34 million23.56APREAprea Therapeutics1.3$26.94+1.4%$559.22 millionN/A-5.77ATHXAthersys1.4$2.78+1.8%$556.04 million$5.63 million-9.27URGNUrogen Pharma1.6$26.58+1.5%$555.52 million$20,000.00-4.59ZFGNZafgen0.9$14.70+8.8%$550.81 millionN/A-15.31PGENPrecigen2.2$3.21+0.6%$547.82 million$90.72 million-1.57Unusual Options ActivityHeavy News ReportingSRDXSurModics1.4$42.24+4.0%$539.88 million$100.08 million86.20LMATLeMaitre Vascular2.3$28.22+4.5%$538.97 million$117.23 million32.44MGTXMeiraGTx1.5$14.35+0.3%$537.61 million$13.29 million-9.70Analyst DowngradeHeavy News ReportingANABAnaptysBio1.2$18.67+2.0%$536.87 million$8 million-6.04APTOAptose Biosciences2.0$7.07+1.3%$534.68 millionN/A-13.34Heavy News ReportingCRNXCrinetics Pharmaceuticals1.4$15.99+3.3%$526.91 million$1.19 million-6.61Analyst DowngradeRUBYRubius Therapeutics2.2$6.37+1.6%$520.68 millionN/A-2.83Analyst UpgradeAUTLAutolus Therapeutics1.4$13.14+0.7%$518.28 million$2.91 million-4.71Analyst ReportBCELAtreca1.6$18.34+0.5%$517.12 millionN/A-3.22Analyst DowngradeInsider SellingSIBNSI-Bone1.7$17.81+2.0%$516.52 million$67.30 million-10.86Insider SellingVKTXViking Therapeutics1.8$7.38+3.4%$516.16 millionN/A-17.57Analyst ReportHeavy News ReportingCVMCel-Sci0.6$13.69+1.3%$515.21 millionN/A0.00Analyst UpgradeANIKAnika Therapeutics1.9$36.96+6.0%$511.20 million$114.51 million20.20CRBPCorbus Pharmaceuticals2.2$6.89+0.0%$508.30 million$36.14 million-6.10Analyst DowngradeUnusual Options ActivityHeavy News ReportingATRSAntares Pharma1.9$3.12+6.4%$504.96 million$123.86 million156.08CLVSClovis Oncology1.7$6.68+3.0%$498.31 million$143.01 million-0.93OMIOwens & Minor2.6$7.89+1.1%$491.48 million$9.21 billion-7.89SRRKScholar Rock1.6$16.99+7.0%$486.05 million$20.49 million-8.50Analyst DowngradeHeavy News ReportingESTAEstablishment Labs2.1$20.64+6.1%$484.31 million$89.57 million-9.74GTSTriple-S Management2.2$19.66+3.5%$484.21 million$3.38 billion14.46BDSIBioDelivery Sciences International1.9$4.81+1.5%$482.52 million$111.39 million-53.44DRRXDURECT1.6$2.41+5.8%$480.26 million$29.56 million-20.08Insider SellingBYSIBeyondspring1.3$17.29+1.5%$474.89 millionN/A-11.30NLTXNeoleukin Therapeutics1.8$12.20+0.1%$468.11 million$25 million-4.57FULCFulcrum Therapeutics1.4$19.04+5.5%$466.53 millionN/A-1.63VBIVVBI Vaccines2.1$2.00+5.0%$465.91 million$2.22 million-5.71FLXNFlexion Therapeutics2.4$12.30+3.4%$463.11 million$72.96 million-3.25Analyst Report This page was last updated on 6/6/2020 by MarketBeat.com Staff
